Research ExplorerScientific StaffStefan Steurer Publications

Dr. ID: 59883

Stefan Steurer

graph of relations
Affiliations
101 - 150 out of 178Page size: 50

Publications

  1. 2019

  2. 5q21 deletion is often heterogeneous in prostate cancer

    Kluth, M., Al Kilani, Z., Özden, C., Hussein, K., Frogh, S., Möller-Koop, C., Burandt, E., Steurer, S., Büscheck, F., Jacobsen, F., Luebke, A. M., Minner, S., Tsourlakis, M. C., Hoeflmayer, D., Wittmer, C., Schlomm, T., Sauter, G., Simon, R. & Wilczak, W., 08.2019, In: GENE CHROMOSOME CANC. 58, 8, p. 509-515 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Expression of the immune checkpoint receptor TIGIT in seminoma

    Hinsch, A., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S. & Wilczak, W., 08.2019, In: ONCOL LETT. 18, 2, p. 1497-1502 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

    Büscheck, F., Zub, M., Heumann, A., Hube-Magg, C., Simon, R., Lang, D. S., Höflmayer, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Sauter, G., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Clauditz, T. S., Burandt, E., Wilczak, W., Steurer, S. & Minner, S., 07.2019, In: TUMOR BIOL. 41, 7, p. 1010428318824815

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. SNW1 is a prognostic biomarker in prostate cancer

    Höflmayer, D., Willich, C., Hube-Magg, C., Simon, R., Lang, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Huland, H., Graefen, M., Haese, A., Heinzer, H., Minner, S., Büscheck, F., Sauter, G., Schlomm, T., Steurer, S., Clauditz, T. S., Burandt, E., Wilczak, W. & Bernreuther, C., 01.05.2019, In: DIAGN PATHOL. 14, 1, p. 33

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

    Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., Tsourlakis, M. C., Minner, S., Simon, R., Sauter, G., Büscheck, F., Jacobsen, F., Hinsch, A., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Clauditz, T. S., Burandt, E., Wilczak, W. & Höflmayer, D., 05.2019, In: CANCER BIOL MED. 16, 2, p. 319-330 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. p53 overexpression is a prognosticator of poor outcome in esophageal cancer

    Melling, N., Norrenbrock, S., Kluth, M., Simon, R., Hube-Magg, C., Steurer, S., Hinsch, A., Burandt, E., Jacobsen, F., Wilczak, W., Quaas, A., Bockhorn, M., Grupp, K., Tachezy, M., Izbicki, J., Sauter, G. & Gebauer, F., 04.2019, In: ONCOL LETT. 17, 4, p. 3826-3834 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

    Schroeder, C., Grell, J., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Höflmayer, D., Minner, S., Burandt, E., Clauditz, T. S., Büscheck, F., Jacobsen, F., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Steurer, S., 01.03.2019, In: BMC CANCER. 19, 1, p. 193

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

    Eichenauer, T., Hussein, M., Hube-Magg, C., Kluth, M., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Beyer, B., Steuber, T., Huland, H., Graefen, M., Simon, R., Sauter, G., Melling, N., Schlomm, T. & Minner, S., 01.03.2019, In: ONCOTARGET. 10, 18, p. 1729-1744 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

    Minner, S., Lutz, J., Hube-Magg, C., Kluth, M., Simon, R., Höflmayer, D., Burandt, E., Tsourlakis, M. C., Sauter, G., Büscheck, F., Wilczak, W., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Jacobsen, F., Hinsch, A., Poos, A., Oswald, M., Rippe, K., König, R. & Schroeder, C., 02.2019, In: PROSTATE. 79, 3, p. 302-311 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

    Mandelkow, T., Blessin, N. C., Lueerss, E., Pott, L., Simon, R., Li, W., Wellge, B., Debatin, N. F., Höflmayer, D., Izbicki, J. R., Büscheck, F., Luebke, A. M., Wittmer, C., Jacobsen, F., Lutz, F., Burandt, E., Steurer, S., Sauter, G., Tsourlakis, M. C., Wilczak, W., Hinsch, A. & Minner, S., 2019, In: DIS MARKERS. 2019, p. 2532518

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

    Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E-C., Steurer, S., Wilczak, W. & Hinsch, A., 2019, In: DIS MARKERS. 2019, p. 5160565

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2018

  14. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

    Li, W., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Pott, L., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S., Wilczak, W. & Hinsch, A., 04.12.2018, In: BMC CANCER. 18, 1, p. 1209

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

    Grupp, K., Hofmann, B., Kutup, A., Bachmann, K., Bogoevski, D., Melling, N., Uzunoglu, F. G., El Gammal, A. T., Koop, C., Simon, R., Steurer, S., Krech, T., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G., Izbicki, J. & Wilczak, W., 12.11.2018, In: BMC CANCER. 18, 1, p. 1106

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

    Kluth, M., Scherzai, S., Büschek, F., Fraune, C., Möller, K., Höflmayer, D., Minner, S., Göbel, C., Möller-Koop, C., Hinsch, A., Neubauer, E., Tsourlakis, M. C., Sauter, G., Heinzer, H., Graefen, M., Wilczak, W., Luebke, A. M., Burandt, E., Steurer, S., Schlomm, T. & Simon, R., 10.2018, In: GENE CHROMOSOME CANC. 57, 10, p. 504-512 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

    Wilczak, W., Wittmer, C., Clauditz, T., Minner, S., Steurer, S., Büscheck, F., Krech, T., Lennartz, M., Harms, L., Leleu, D., Ahrens, M., Ingwerth, S., Günther, C. T., Koop, C., Simon, R., Jacobsen, F., Tsourlakis, M. C., Chirico, V., Höflmayer, D., Vettorazzi, E., Haese, A., Steuber, T., Salomon, G., Michl, U., Budäus, L., Tilki, D., Thederan, I., Fraune, C., Göbel, C., Henrich, M-C., Juhnke, M., Möller, K., Bawahab, A. A., Uhlig, R., Adam, M., Weidemann, S., Beyer, B., Huland, H., Graefen, M., Sauter, G. & Schlomm, T., 09.2018, In: EUR UROL. 74, 3, p. 376-386 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Immunohistochemically detected IDH1 mutation is rare and mostly heterogeneous in prostate cancer

    Hinsch, A., Brolund, M., Hube-Magg, C., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Steurer, S., Luebke, A., Angerer, A., Wittmer, C., Neubauer, E., Göbel, C., Büscheck, F., Minner, S., Wilczak, W., Schlomm, T., Jacobsen, F., Clauditz, T. S., Krech, T., Tsourlakis, M. C. & Schroeder, C., 06.2018, In: WORLD J UROL. 36, 6, p. 877-882 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Sauter, G., Clauditz, T., Steurer, S., Wittmer, C., Büscheck, F., Krech, T., Lutz, F., Lennartz, M., Harms, L., Lawrenz, L., Möller-Koop, C., Simon, R., Jacobsen, F., Wilczak, W., Minner, S., Tsourlakis, M. C., Chirico, V., Weidemann, S., Haese, A., Steuber, T., Salomon, G., Matiu, M., Vettorazzi, E., Michl, U., Budäus, L., Tilki, D., Thederan, I., Pehrke, D., Beyer, B., Fraune, C., Göbel, C., Heinrich, M., Juhnke, M., Möller, K., Bawahab, A. A. A., Uhlig, R., Huland, H., Heinzer, H., Graefen, M. & Schlomm, T., 05.2018, In: EUR UROL. 73, 5, p. 674-683 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

    Heumann, A., Heinemann, N., Hube-Magg, C., Lang, D. S., Grupp, K., Kluth, M., Minner, S., Möller-Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wilczak, W., Wittmer, C., Jacobsen, F., Huland, H., Simon, R., Schlomm, T., Sauter, G., Steurer, S., Lebok, P. & Hinsch, A., 05.01.2018, In: BMC CANCER. 18, 1, p. 37

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor Features: A tissue microarray study on 8,877 human cancers and normal tissues

    Burdelski, C., Jakani-Karimi, N., Jacobsen, F., Möller-Koop, C., Minner, S., Simon, R., Sauter, G., Steurer, S., Clauditz, T. S. & Wilczak, W., 01.2018, In: ONCOL REP. 39, 1, p. 3-12 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases

    Gerstenberger, W., Wrage, M., Kettunen, E., Pantel, K., Anttila, S., Steurer, S. & Wikman, H., 2018, In: ANAL CELL PATHOL. 2018, p. 8651790

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. 2017

  24. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

    Tsourlakis, M. C., Eleftheriadou, A., Stender, A., Weigand, P., Grupp, K., Hube-Magg, C., Kluth, M., Schroeder, C., Steurer, S., Hinsch, A., Luebke, A., Angerer, A., Wittmer, C., Friedrich, E., Göbel, C., Büscheck, F., Heinzer, H., Graefen, M., Simon, R., Sauter, G., Wilczak, W., Minner, S., Schlomm, T. & Jacobsen, F., 07.12.2017, In: CARCINOGENESIS. 38, 12, p. 1180-1187 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

    Person, F., Wilczak, W., Hube-Magg, C., Burdelski, C., Möller-Koop, C., Simon, R., Noriega, M., Sauter, G., Steurer, S., Burdak-Rothkamm, S. & Jacobsen, F., 10.2017, In: TUMOR BIOL. 39, 10, p. 1010428317712166

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

    Steurer, S., Rico, S. D., Simon, R., Minner, S., Tsourlakis, M. C., Krech, T., Koop, C., Graefen, M., Heinzer, H., Adam, M., Huland, H., Schlomm, T., Sauter, G. & Lumiani, A., 09.2017, In: BJU INT. 120, 3, p. 365-376 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

    Burdelski, C., Borcherding, L., Kluth, M., Hube-Magg, C., Melling, N., Simon, R., Möller-Koop, C., Weigand, P., Minner, S., Haese, A., Michl, H. U., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Izbicki, J. R., Sauter, G., Krech, T., Büscheck, F., Clauditz, T., Schlomm, T. & Wilczak, W., 09.05.2017, In: ONCOTARGET. 8, 19, p. 31494-31508 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

    Burdelski, C., Fitzner, M., Hube-Magg, C., Kluth, M., Heumann, A., Simon, R., Krech, T., Clauditz, T., Büscheck, F., Steurer, S., Wittmer, C., Hinsch, A., Luebke, A. M., Jacobsen, F., Minner, S., Tsourlakis, M. C., Beyer, B., Steuber, T., Thederan, I., Sauter, G., Izbicki, J., Schlomm, T. & Wilczak, W., 04.2017, In: NEOPLASIA. 19, 4, p. 279-287 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays

    Hinsch, A., Buchholz, M., Odinga, S., Borkowski, C., Koop, C., Izbicki, J. R., Wurlitzer, M., Krech, T., Wilczak, W., Steurer, S., Jacobsen, F., Burandt, E-C., Stahl, P., Simon, R., Sauter, G. & Schlüter, H., 03.2017, In: J MASS SPECTROM. 52, 3, p. 165-173

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. βIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer

    Hinsch, A., Chaker, A., Burdelski, C., Koop, C., Tsourlakis, M. C., Steurer, S., Rink, M., Eichenauer, T. S., Wilczak, W., Wittmer, C., Fisch, M., Simon, R., Sauter, G., Büschek, F., Clauditz, T., Minner, S. & Jacobsen, F., 03.2017, In: HUM PATHOL. 61, p. 210-220

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

    Melling, N., Rashed, M., Schroeder, C., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Möller-Koop, C., Steurer, S., Sauter, G., Jacobsen, F., Büscheck, F., Wittmer, C., Clauditz, T., Krech, T., Tsourlakis, M. C., Minner, S., Huland, H., Graefen, M., Budäus, L., Thederan, I., Salomon, G., Schlomm, T. & Wilczak, W., 29.01.2017, In: INT J MOL SCI. 18, 2, p. 286

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 10.01.2017, In: ONCOTARGET. 8, 2, p. 3761

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  33. Deletion of 8p is an independent prognostic parameter in prostate cancer

    Kluth, M., Amschler, N. N., Galal, R., Möller-Koop, C., Barrow, P., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Steurer, S., Krech, T., Büscheck, F., Clauditz, T. S., Beyer, B., Wilczak, W., Graefen, M., Huland, H., Minner, S., Schlomm, T., Sauter, G. & Simon, R., 03.01.2017, In: ONCOTARGET. 8, 1, p. 379-392 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

    Wilczak, W., Rashed, S., Hube-Magg, C., Kluth, M., Simon, R., Büscheck, F., Clauditz, T. S., Grupp, K., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Sauter, G., Izbicki, J. R., Huland, H., Schlomm, T., Steurer, S., Krech, T. & Lebok, P., 01.2017, In: CARCINOGENESIS. 38, 1, p. 19-27

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2016

  36. Deletion of 18q is a strong and independent prognostic feature in prostate cancer

    Kluth, M., Graunke, M., Koop, C., Hube-Magg, C., Minner, S., Michl, U., Graefen, M., Huland, H., Pompe, R., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Büscheck, F., Clauditz, T., Wilczak, W., Sauter, G., Schlomm, T. & Simon, R., 27.12.2016, In: ONCOTARGET. 7, 52, p. 86339-86349 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease

    Pelczar, P., Witkowski, M., Perez, L. G., Kempski, J., Hammel, A. G., Brockmann, L., Kleinschmidt, D., Wende, S., Haueis, C., Bedke, T., Krasemann, S., Steurer, S., Booth, C. J., Busch, C. P., König, A., Rauch, U., Benten, D., Izbicki, J. R., Rösch, T., Lohse, A. W., Strowig, T., Gagliani, N., Flavell, R. A. & Huber, S., 21.10.2016, In: SCIENCE. 354, 6310, p. 358-362

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients

    Tsourlakis, M-C., Stender, A., Quaas, A., Kluth, M., Wittmer, C., Haese, A., Graefen, M., Steurer, S., Simon, R., Korbel, J., Weischenfeldt, J., Huland, H., Sauter, G., Schlomm, T. & Minner, S., 17.08.2016, In: BMC CANCER. 16, p. 641

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Sauter, G., Steurer, S., Clauditz, T. S., Krech, T., Wittmer, C., Lutz, F., Lennartz, M., Janssen, T., Hakimi, N., Simon, R., von Petersdorff-Campen, M., Jacobsen, F., Loga, K., Wilczak, W., Minner, S., Tsourlakis, M. C., Chirico, V., Haese, A., Heinzer, H., Beyer, B., Graefen, M., Michl, U., Salomon, G., Steuber, T., Budäus, L. H., Hekeler, E., Malsy-Mink, J., Kutzera, S., Fraune, C., Göbel, C., Huland, H. & Schlomm, T., 01.04.2016, In: EUR UROL. 69, 4, p. 592-8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

    Burdelski, C., Kleinhans, S., Kluth, M., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wilczak, W., Marx, A., Sauter, G., Wittmer, C., Huland, H., Simon, R., Schlomm, T. & Steurer, S., 01.03.2016, In: INT J CANCER. 138, 5, p. 1199-206

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

    Pust, A., Kylies, D., Hube-Magg, C., Kluth, M., Minner, S., Koop, C., Grob, T., Graefen, M., Salomon, G., Tsourlakis, M. C., Izbicki, J., Wittmer, C., Huland, H., Simon, R., Wilczak, W., Sauter, G., Steurer, S., Krech, T., Schlomm, T. & Melling, N., 02.2016, In: HUM PATHOL. 48, p. 102-10 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

    Melling, N., Taskin, B., Hube-Magg, C., Kluth, M., Minner, S., Koop, C., Grob, T., Graefen, M., Heinzer, H., Tsourlakis, M. C., Izbicki, J., Wittmer, C., Huland, H., Simon, R., Wilczak, W., Sauter, G., Steurer, S., Schlomm, T. & Krech, T., 02.2016, In: PROSTATE. 76, 3, p. 259-72 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

    Kluth, M., Meyer, D., Krohn, A., Freudenthaler, F., Bauer, M., Salomon, G., Heinzer, H., Michl, U., Steurer, S., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 26.01.2016, In: ONCOTARGET. 7, 4, p. 3897-904

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. 2015

  45. Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer

    Kluth, M., Runte, F., Barow, P., Omari, J., Abdelaziz, Z. M., Paustian, L., Steurer, S., Christina Tsourlakis, M., Fisch, M., Graefen, M., Tennstedt, P., Huland, H., Michl, U., Minner, S., Sauter, G., Simon, R., Adam, M. & Schlomm, T., 15.11.2015, In: INT J CANCER. 137, 10, p. 2354-63 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

    Melling, N., Thomsen, E., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Wilczak, W., Huland, H., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 11.2015, In: CARCINOGENESIS. 36, 11, p. 1333-40 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma

    Quaas, A., Rahvar, A-H., Burdelski, C., Koop, C., Eichelberg, C., Rink, M., Dahlem, R., Schlomm, T., Tsourlakis, M. C., Simon, R., Minner, S., Sauter, G. & Steurer, S., 10.2015, In: WORLD J UROL. 33, 10, p. 1561-1569

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 29.09.2015, In: ONCOTARGET. 6, 29, p. 27966-79 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

    Grupp, K., Roettger, L., Kluth, M., Hube-Magg, C., Simon, R., Lebok, P., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Sauter, G., Wilczak, W., Huland, H., Schlomm, T., Steurer, S. & Krech, T., 09.2015, In: Oncology reports. 34, 3, p. 1211-20 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

    Burdelski, C., Reiswich, V., Hube-Magg, C., Kluth, M., Minner, S., Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wittmer, C., Huland, H., Simon, R., Schlomm, T., Sauter, G. & Steurer, S., 01.08.2015, In: CLIN CANCER RES. 21, 15, p. 3471-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility

    Schiffmann, J., Wenzel, P., Salomon, G., Budäus, L., Schlomm, T., Minner, S., Wittmer, C., Kraft, S., Krech, T., Steurer, S., Sauter, G., Beyer, B., Boehm, K., Tilki, D., Michl, U., Huland, H., Graefen, M. & Karakiewicz, P. I., 07.2015, In: UROL ONCOL-SEMIN ORI. 33, 7, p. 329.e13-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

    Burdelski, C., Barreau, Y., Simon, R., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Sauter, G., Wittmer, C., Steurer, S., Adam, M., Huland, H., Schlomm, T., Tsourlakis, M. C. & Quaas, A., 01.04.2015, In: HUM PATHOL. 46, 4, p. 514-23 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

    Zabalza, C. V., Adam, M., Burdelski, C., Wilczak, W., Wittmer, C., Kraft, S., Krech, T., Steurer, S., Koop, C., Hube-Magg, C., Graefen, M., Heinzer, H., Minner, S., Simon, R., Sauter, G., Schlomm, T. & Tsourlakis, M. C., 23.03.2015, In: ONCOTARGET. 6, 14, p. 12822-12834

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

    Burdelski, C., Ruge, O. M., Melling, N., Koop, C., Simon, R., Steurer, S., Sauter, G., Kluth, M., Hube-Magg, C., Minner, S., Wittmer, C., Wilczak, W., Hinsch, A., Lebok, P., Izbicki, J. R., Heinzer, H., Graefen, M., Huland, H., Schlomm, T. & Krech, T., 18.03.2015, In: EXP MOL PATHOL. 98, 3, p. 419-426 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    Burdelski, C., Strauss, C., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Melling, N., Lebok, P., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Krech, T., Sauter, G., Wilczak, W., Simon, R., Schlomm, T. & Steurer, S., 25.02.2015, In: ONCOTARGET.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 Next